Medical Device

PA Court Vacates $28 Million Verdict in Knee Replacement Case

January 7, 2014
/
Litigation Medical Device News Product Liability Verdicts
/

A Pennsylvania Superior Court recently vacated a $27.6 million jury verdict against medical device manufacturer Zimmer Inc. (Zimmer), and marketing firm Public Communications, Inc. (PCI) in a case that involved Zimmer’s Gender Solutions Knee. The decision, which vacated the verdict on causation grounds, is available here. Zimmer’s Gender Solutions Knee is a knee replacement device specifically designed and manufactured for women. Zimmer hired PCI to produce a sales video featuring footage of patients who had received the Gender Solutions Knee. The plaintiff Margo Polett…
Continue reading...

This Week’s Life Science Headlines

January 2, 2014
/
Class Action Design Defect FDA Litigation Medical Device Nutritional Supplements Pharmaceuticals Product Liability Recalls Regulatory Settlements
/

Life Science Matters

Litigation

Regulatory

Product Liability Regulation to Watch in 2014 (subscription required)
Antabloc Manufacturers Get FDA Warning Letter Over IBD Claims

Recalls

Voluntary Field Corrective Action Initiated for Vital Signs Devices’ CO2 Multi Absorber Due to

This Week’s Life Science Headlines

December 26, 2013
/
FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory
/

Life Science Matters

Litigation

NECC Fungal Meningitis Settlement May Result in $100M Payment
MDL Consolidation for Lipitor Diabetes Lawsuits to be Considered Jan. 30
J&J Risperdal Whistleblower Made Millions in Settlement
Generic Fosamax Users Must Give More Details in MDL (subscription required)
JPML Centralizes Glucosamine False Ad Suits (subscription required)
Boehringer May Face More Sanctions in Pradaxa MDL (subscription required)

Regulatory

This Week’s Life Science Headlines

December 19, 2013
/
Class Action Design Defect FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory Settlements Verdicts
/

Life Science Matters

Litigation

3^rd Circ. Doubts Jurisdiction In Generic-Fosamax Appeal (subscription required)
Mirena IUD Lawsuit Discovery Continues in New Jersey and MDL
Abbott Ordered to Produce “Overdue” Docs in Depakote Lawsuits
J&J Fights Attys’ Pursuit of Confidential Risperdal Docs (subscription required)
Pain-Pump Seller SJO Lied to Get $10M Policy, Insurer Says (subscription required)
Stryker Inks 1^st Settlements in NJ Hip Implant Suits (subscription required)
Eli Lilly Defeats Soldier’s Cymbalta “Brain Zap” Suit (subscription required)
4^th Circ. Questions Basis for Generic-Drug

New Liver Disease Medical Device May Help Cut Number of Transplants

December 16, 2013
/
FDA Medical Device News
/

Lisa M. Robinson

Royal Free Hospital in London is conducting a trial of a new medical device to treat liver disease on a group of patients with severe alcohol-related liver failure. Results have already shown that that patients’ liver damage can be reversed, which can dramatically improve a patient’s quality of life. The new device, called an alfapump, is manufactured by the Swiss medical device company Sequana Medical and may radically change the treatment options for patients with severe liver disease in the future. Liver disease impacts the…
Continue reading...

This Week’s Life Science Headlines

December 13, 2013
/
Design Defect FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory Settlements Verdicts
/

Life Science Matters

Litigation

High Court Denies Bid to Review Neurontin RICO Rulings (subscription required)
Merck Settles Fosamax Jaw-Injury Claims for $28M (subscription required)
Boehringer Fined $1M For Withholding Docs in MDL (subscription required)
Expert Testimony Must be Backed By Science, Pa. Court Rules (subscription required)
High Court Passes on Lupron Labeling Suit (subscription required)
1st Circ. Ends Takeda FCA Suit But Limits Scope of Ruling (subscription required)
Medtronic Escapes Jury’s $18M Surgical Fire Verdict (subscription required)
J&J Keeps Vaginal Mesh Suit Out of

The US Food & Drug Administration is Looking into Whether Morning-After Emergency Contraceptive Pills Fail to Work in Women Over a Certain Weight

December 9, 2013
/
FDA Medical Device News Pharmaceuticals Pharmacy Product Liability
/

Life Science Matters

The FDA quickly addressed a recent report that European health regulators have ordered a label change on an emergency contraceptive product sold by French drugmaker HRA Pharma under the brand name Norlevo(levonorgestrel). The European authorities now require the drug’s labeling to address the potential that there is diminishing effectiveness of the pill depending upon the weight of the user. According to HRA, the emergency contraceptive begins to lose its effectivness for wormn who weigh more than 165 pounds and is completely ineffective for women…
Continue reading...